Olanzapine for delirium in parkinsonism: therapeutic benefits in lieu of adverse consequences. | Neurol India; 2004 Jun; 52(2): 274-5 | IMSEAR

Main content 1 Search 2 Footer 3

+A A -A High contrast

Olanzapine for delirium in parkinsonism: therapeutic benefits in lieu of adverse consequences.

Gupta, N; Sharma, Parveen; Prabhakar, S.

Neurol India ; 2004 Jun; 52(2): 274-5

Article in En | IMSEAR | ID: sea-120281

Subject(s)

Adult; Antipsychotic Agents/adverse effects; Benzodiazepines/adverse effects; Delirium/drug therapy; Female; Humans; Parkinsonian Disorders/psychology

Search on Google

Full text: 1 Index: IMSEAR Main subject: Antipsychotic Agents / Benzodiazepines / Female / Humans / Adult / Parkinsonian Disorders / Delirium Language: En Journal: Neurol India Year: 2004 Type: Article

Search on Google

Full text: 1 Index: IMSEAR Main subject: Antipsychotic Agents / Benzodiazepines / Female / Humans / Adult / Parkinsonian Disorders / Delirium Language: En Journal: Neurol India Year: 2004 Type: Article